LUCY SCIENTIFIC DISCOVERY IN (LSDI) Stock Price & Overview

NASDAQ:LSDI • CA54960E2033

Current stock price

0.5139 USD
-0.16 (-23.29%)
At close:
0.4552 USD
-0.06 (-11.42%)
After Hours:

The current stock price of LSDI is 0.5139 USD. Today LSDI is down by -23.29%. In the past month the price decreased by -40.24%. In the past year, price decreased by -95.53%.

LSDI Key Statistics

52-Week Range0.4404 - 12.8
Current LSDI stock price positioned within its 52-week range.
1-Month Range0.4801 - 0.93
Current LSDI stock price positioned within its 1-month range.
Market Cap
904.464K
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-7.20
Dividend Yield
N/A

LSDI Stock Performance

Today
-23.29%
1 Week
-24.87%
1 Month
-40.24%
3 Months
-63.08%
Longer-term
6 Months -79.93%
1 Year -95.53%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

LSDI Stock Chart

LUCY SCIENTIFIC DISCOVERY IN / LSDI Daily stock chart

LSDI Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to LSDI. When comparing the yearly performance of all stocks, LSDI is a bad performer in the overall market: 99.24% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

LSDI Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to LSDI. LSDI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LSDI Earnings

On February 13, 2024 LSDI reported an EPS of -1.4 and a revenue of 6.00K. The company missed EPS expectations (-357.52% surprise) and missed revenue expectations (-96.54% surprise).

Next Earnings DateN/A
Last Earnings DateFeb 13, 2024
PeriodQ2 / 2024
EPS Reported-$1.40
Revenue Reported6K
EPS Surprise -357.52%
Revenue Surprise -96.54%

LSDI Forecast & Estimates

7 analysts have analysed LSDI and the average price target is 35.7 USD. This implies a price increase of 6846.88% is expected in the next year compared to the current price of 0.5139.


Analysts
Analysts82.86
Price Target35.7 (6846.88%)
EPS Next Y78.1%
Revenue Next YearN/A

LSDI Groups

Sector & Classification

Sub-Industry
Pharmaceuticals
Index Membership

LSDI Financial Highlights

Over the last trailing twelve months LSDI reported a non-GAAP Earnings per Share(EPS) of -7.2. The EPS decreased by -96.67% compared to the year before.


Income Statements
Revenue(TTM)16.70K
Net Income(TTM)-11.30M
Industry RankSector Rank
PM (TTM) N/A
ROA -263.59%
ROE -13916.75%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-66.29%
Sales Q2Q%N/A
EPS 1Y (TTM)-96.67%
Revenue 1Y (TTM)N/A

LSDI Ownership

Ownership
Inst Owners7.28%
Shares1.76M
Float1.23M
Ins Owners65.53%
Short Float %N/A
Short RatioN/A

About LSDI

Company Profile

LSDI logo image Lucy Scientific Discovery, Inc. operates as a psychotropics contract manufacturing company. The company is headquartered in Victoria, British Columbia. The company went IPO on 2023-02-09. The firm is engaged in researching, developing, and manufacturing psychotropic drugs. The firm is a manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies. The company is focused on developing therapies for patients in need, and through its lead candidate SANA-013, dedicated to advancing the understanding and applications of psychedelic medicine, improving mental health outcomes, and enhancing well-being for individuals worldwide. The firm is engaged in the production of a variety of natural, synthetic, and biosynthetic products to meet the needs of the psychotropics-based medicines market. Its products are in the form of raw materials, crude extracts, targeted formulations, single molecule fractions, and white- and private-label products.

Company Info

IPO: 2023-02-09

LUCY SCIENTIFIC DISCOVERY IN

301-1321 Blanshard Street

Victoria BRITISH COLUMBIA CA

Employees: 0

LSDI Company Website

Phone: 17784105195

LUCY SCIENTIFIC DISCOVERY IN / LSDI FAQ

Can you describe the business of LUCY SCIENTIFIC DISCOVERY IN?

Lucy Scientific Discovery, Inc. operates as a psychotropics contract manufacturing company. The company is headquartered in Victoria, British Columbia. The company went IPO on 2023-02-09. The firm is engaged in researching, developing, and manufacturing psychotropic drugs. The firm is a manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies. The company is focused on developing therapies for patients in need, and through its lead candidate SANA-013, dedicated to advancing the understanding and applications of psychedelic medicine, improving mental health outcomes, and enhancing well-being for individuals worldwide. The firm is engaged in the production of a variety of natural, synthetic, and biosynthetic products to meet the needs of the psychotropics-based medicines market. Its products are in the form of raw materials, crude extracts, targeted formulations, single molecule fractions, and white- and private-label products.


What is the current price of LSDI stock?

The current stock price of LSDI is 0.5139 USD. The price decreased by -23.29% in the last trading session.


Does LUCY SCIENTIFIC DISCOVERY IN pay dividends?

LSDI does not pay a dividend.


What is the ChartMill technical and fundamental rating of LSDI stock?

LSDI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What is the Price/Earnings (PE) ratio of LUCY SCIENTIFIC DISCOVERY IN (LSDI)?

LUCY SCIENTIFIC DISCOVERY IN (LSDI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-7.2).


Would investing in LUCY SCIENTIFIC DISCOVERY IN be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on LSDI.